Ethics of Risk Analysis and Regulatory Review: From Bio- to Nanotechnology

Jennifer Kuzma1, John C. Besley2
1Center for Science, Technology and Public Policy, Humphrey Institute of Public Affairs, University of Minnesota, Minneapolis, USA
2School of Journalism and Mass Communications, University of South Carolina, Columbia, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Adams JS (1965) Inequity in social exchange. In: Berkowitz L (ed) Advances in Experimental Social Psychology. Academic Press, New York, pp 267–299

Ag BiotechBuzz (2002a) Journal and Mexican government disagree over corn contamination. Volume 2, Issue 4. April 30. Retrieved August 8, 2007 from http://pewagbiotech.org/buzz/display.php3?StoryID=55

AgBiotech Buzz (2002b) Of famine and food aid: GM food internationally global GM volume 2, issue 9, spotlight, October 2. Retrieved August 8, 2007 from http://pewagbiotech.org/buzz/print.php3?StoryID=77

APHA (2002) Preserving right-to-know information and encouraging hazard reduction to reduce the risk of exposure to toxic substances. APHA, Washington, DC (November 13). Policy number 2002–2003. Retrieved August 8, 2007 from http://www.apha.org/legislative/policy/policysearch/index.cfm?fuseaction=view&id=279

Beauchamp TL, Walters L (1999) Ethical theory and bioethics. In: Beauchamp T, Walters L (eds) Contemporary issues in bioethics. 5th edn. Wadsworth, Belmont, CA, pp 1–32

Beauchamp TL, Childress JF (2001) Principles of biomedical ethics, 5th edn. Oxford University Press, Oxford, UK

Bekelman JE, Li Y, Gross CP (2003) Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289:454–465

Besley JC, McComas KA (2005) Framing justice: using the concept of procedural justice to advance political communication research. Commun Theory 15(4):414–436

Besley JC, McComas KA, Waks L (2006) Media use and the perceived justice of local science authorities. Journal Mass Commun Q 83(4):801–818

Bohannon J (2002) Zambia rejects GM corn on scientists’ advice. Science 298:1153–1154

Bozeman B, Sarewitz D (2005) Public values and public failure in U.S. Science policy. Sci Public Policy 32(2):119–136

Burkhardt J (2001) The GMO debates: taking ethics seriously. Retrieved August 8, 2007 from http://www.farmfoundation.org/2001NPPEC/burkhardt.pdf

CNS-ASU (2005) RTTA program 3: deliberation and participation. Retrieved December 31, 2007 from http://cns.asu.edu/program/rtta3.htm

CNS-UCSB (2007) Education and public engagement. Retrieved January 3, 2007 from http://www.cns.ucsb.edu/education-public-engagement/

Cho M, Bero L (1996) The quality of drug studies published in symposium proceedings. Ann Intern Med 124:495–489

Cobb MD, Macoubrie J (2004) Public perceptions about nanotechnology: risks benefits and trust. J Nanopart Res 6:395–405

Colquitt JA (2001) On the dimensionality of organizational justice: A construct validation of a measure. J Appl Psychol 86(3):386–400

Colquitt JA, Shaw JC (2005) How should organizational justice be measured? In: Greenberg J, Colquitt JA (eds) Handbook of Organizational Justice. Lawrence Erlbaum Associates, Mahwah, NJ, pp 113–152

Colquitt JA, Greenberg J, Zapata-Phelan CP (2005) What is organizational justice? A historical overview. In: Greenberg J, Colquitt JA (eds) Handbook of organizational justice. Lawrence Erlbaum, Mahwah, NJ, pp 3–58

Davies C (2006) Managing the effects of nanotechnology. PEN 2, Washington, DC. Retrieved August 8, 2007 from project on emerging nanotechnologies website: www.nanotechproejct.org

Davies C (2007) EPA and nanotechnology: oversight for the 21st century. PEN 9, Washington, DC. Retrieved August 8, 2007 from project on emerging nanotechnologies website: www.nanotechproejct.org

Ebbesen M, Andersen S, Besenbacher F (2006) Ethics in nanotechnology: starting from scratch? Bull Sci Technol Soc 26(6):451–462

Einsiedel EF, Goldenberg L (2006) Dwarfing the social? Nanotechnology lessons from the biotechnology front. In: Hunt G, Mehta M (eds) Nanotechnology: risk, ethics, and law. Earthscan, London, UK, pp 213–221

EPA (1983) Guidelines for performing regulatory impact analysis, EPA-230-01-84-003. US Government Printing Office, Washington, DC

EPA (2007) Nanoscale materials stewardship program and inventory status of nanoscale substances under the Toxic Substances Control Act; notice of availability. Fed Regist 72(133):38083–38085 July

EOP (1993) Executive office of the president: regulatory review and planning, executive order 12866. Federal Register 58(190):51735–51744 October

FDA (1995) U. S. food and drug administration center for food safety and applied nutrition CFSAN handout: 1995 FDA’S policy for foods developed by biotechnology. Retrieved August 8, 2007 from http://vm.cfsan.fda.gov/∼lrd/biopolcy.html

FDA (2007) Nanotechnology: a report of the U.S. food and drug administration nanotechnology task force, July 25, 2007. Retrieved August 8, 2007 from http://www.fda.gov/nanotechnology/taskforce/report2007.pdf

Gastil J, Levine P (eds) (2005) The deliberative democracy handbook: strategies for effective engagement in the twenty-first century. Jossey-Bass, San Francisco, CA

Greenberg J (1993) The social side of fairness: Interpersonal and informational classes of organizational justice. In: Cropanzano R (ed) Justice in the Workplace: Approaching Fairness in Human Resource Management. Erlbaum, Hillsdale, NJ, pp 79–103

Guston DH, Sarewitz D (2002) Real-time technology assessment. Technol Soc 24:93–109

Gutmann A, Thompson D (2004) Why deliberative democracy. Princeton University Press, Princeton, NJ

Hart PD (2006) Attitudes toward nanotechnology. Woodrow Wilson International Center, Washington DC (September). Retrieved August 8, 2007 from http://www.nanotechproject.org

ICTA (2007) International Center for Technology Assessment (ICTA) (2007). Principles for the oversight of nanotechnologies and nanomaterials. August 5, 2007. Retrieved August 8, 2007 from http://www.icta.org/doc/Principles%20for%20the%20Oversight%20of%20Nanotechnologies%20and%20Nanomaterials_final.pdf

James C (2007) Global status of commercialized biotech/GM crops: 2006. ISAAA Brief 35–2006

Joss S, Belluci S (eds) (2002) Participatory technology assessment: European perspectives. Athenaeum, Gateshead, UK

Kaiser J (2007) Stung by controversy, biomedical groups urge consistent guidelines. Science 317:441

Khushf G (2004) The ethics of nanotechnology: vision and values for a new generation of science and engineering. In: Emerging technologies and ethical issues in engineering: papers from a workshop, October 14–15, 2003. National Academies Press, Washington, DC, pp 29–56

Krimsky S, Rothenberg LS, Stott P, Kyle G (1998) Scientific journals and their authors’ financial interests: a pilot study. Psychother Psychosom 67:194–201

Kuzma J (2006) Nanotechnology oversight: just do it. Environ Law Rep 36:10913–10923

Kuzma J (2007) Moving forward responsibility: oversight for the nanotechnology biology interface. J Nanopart Res 9:65–182

Kuzma J, Romanchek J, Kokotovich A (2007) Upstream oversight assessment for agrifood nanotechnology: a case studies approach. Risk Analysis (in press)

Lane N, Kalil T (2005) The national nanotechnology initiative: present at the creation. Issues Sci Technol 21(4):51–52 Summer

Lee CJ, Scheufele DA, Lewenstein BV (2005) Public attitudes toward emerging technologies—examining the interactive effects of cognitions and affect on public attitudes toward nanotechnology. Sci Commun 27(2):240–267

Lewenstein B (2005) What counts as a ‘social and ethical issue’ in nanotechnology? HYLE 11(1):5–18

Losey JE, Rayor LS, Carter ME (1999) Transgenic pollen harms monarch larvae. Nature 399:214

Macnaghten P, Kearnes MB, Wynne B (2005) Nanotechnology, governance, and public deliberation: what role for the social sciences? Sci Commun 27(2):268–291

Macoubrie J (2005) Informed public perceptions of nanotechnology and trust in government. Projects on emerging nanotechnologies, Woodrow Wilson International Center for Scholars. Retrieved August 8, 2007 from http://www.wilsoncenter.org/index.cfm?topic_id=166192&fuseaction=topics.event_summary&event_id=143410 , September

Macoubrie J (2006) Nanotechnology: public concerns, reasoning, and trust in government. Public Underst Sci 15:221–241

Mann C (2002a) Has GM corn ‘invaded’ Mexico? Science 295:1617–1618

Mann C (2002b) Transgene data deemed unconvincing. Science 296:236–237

Maynard A (2006) Nanotechnology: a research strategy for addressing risk. Project on emerging nanotechnologies: Washington DC. Retrieved August 8, 2007 from http://www.nanotechproject.org

McComas KA, Trumbo CW, Besley JC (2007) Public meetings about suspected cancer clusters: the impact of voice, interactional justice, and risk perception on attendees’ attitudes in six communities. J Health Commun 12:527–549

Miller HI, Conko G (2001) Precaution without principle. Nat Biotechnol 19:302–303

Miller HI (2002) Nescience, not science, from the academy. Scientist 16(19):12–14

Morgan G, Henrion M (1990) The nature and sources of uncertainty. In: Morgan G, Henrion M (eds) Uncertainty. Cambridge University Press, Cambridge, pp 16–46

Michigan State University (MSU) (2005) First international IFAS conference on nanotechnology. What can nano learn from bio? Lessons from the debate over agrifood biotechnology and GMOs, October 26–27, 2005, at Michigan State University (USA). Retrieved August 8, 2007 from http://www.ifas.msu.edu/nanoconference.htm

National Nanotechnology Initiative (NNI) (2007) What is nanotechnology? Retrieved on June 5, 2007, from http://www.nano.gov/html/facts/whatIsNano.html

Nelson R, Weiss R (1999) Hasty decisions in the race to a cure?: Gene therapy study proceeded despite safety, ethics concerns,” Washington Post, November 21, p A1

National Research Council (NRC) (1996) Understanding risk. National Academy, Washington, DC

National Research Council (NRC) (2000) Genetically modified pest-protected plants: Science and regulation. National Academy, Washington, D.C.

National Research Council (NRC) (2002) Environmental effects of transgenic plants. National research council. National Academy, Washington, D.C.

OMBWatch (2007) Assistance for 10.219: biotechnology risk assessment research, (FY 2000–2006) Retrieved August 8, 2007 from http://www.fedspending.org/faads/faads.php?&cfda_program_num=10.219&sortby=u&datype=T&reptype=a&database=faads&detail=2

Office of Science and Technology Policy (OSTP) (2000) Food and agricultural biotechnology initiatives: strengthening science-based regulation. May 3, 2000. Retrieved August 8, 2007 from http://clinton4.nara.gov/WH/EOP/OSTP/html/0058.html

Pidgeon N (2006) Opportunities and uncertainties—the British nanotechnologies report and the case for upstream societal dialogue. Conference-paper: VALDOR. Stockholm, Sweeden. Retrieved August 8, 2007 from http://www.congrex.com/valdor2006/papers/53_Pidgeon.pdf

Pew Initiative on Food and Biotechnology (PIFB) (2002) Three years later: lessons learned from the monarch butterfly controversy. Retrieved August 8, 2007 from http://pewagbiotech.org/resources/issuebriefs/monarch.pdf

Pew Initiative on Food and Biotechnology (PIFB) (2003a) Have genes, will travel. Retrieved August 8, 2007 from http://pewagbiotech.org/resources/issuebriefs/geneflow.pdf

Pew Initiative on Food and Biotechnology (PIFB) (2003b) University-industry relationship: framing the issues for academic research in agricultural biotechnology. Retrieved August 8, 2007 from http://pewagbiotech.org/research/UIR.pdf

Pew Initiative on Food and Biotechnology (PIFB) (2005) An examination of the trade issues surrounding genetically modified food. Retrieved August 8, 2007 from http://pewagbiotech.org/resources/issuebriefs/useu.pdf

Press E, Washburn J (2000) The kept university. Atl Mon 285:39–54

Quist D, Chapela I (2001) Transgenic DNA introgressed into traditional maize landraces in Oaxaca, Mexico. Nature 414:541–543

Rendtorff JD, Kemp P (2000) Basic ethical principles in European bioethics and biolaw, vol i–ii. Institut Borja di bioètica and Centre for Ethics and Law, Barcelona and Copenhagen

Rendtorff JD (2002) Basic ethical principles in European bioethics and biolaw: autonomy, dignity, integrity and vulnerability—towards a foundation of bioethics and biolaw. Med Health Care Philos 5:235–244

Rodenmeyer M (2002) Corn fight: science suffers when the debate gets personal. San Francisco Chronicle, Tuesday, April 30

Rowe G, Frewer LJ (2004) Evaluating public-participation exercises: a research agenda. Sci Technol Human Values 29(4):512–557

Rollin B (1986) The Frankenstein thing. In: Evans JW, Hollaender A (eds) Genetic engineering of animals: an agricultural perspective. Plenum, New York, pp 285–298

The Royal Society and Royal Academy of Engineering (2004) Nanoscience and nanotechnologies: opportunities and uncertainties. The Royal Society, London July

Science (2003) On campus. Science 302:2065

Sears MK, Hellmich RL, Stanley-Horn DE, Oberhauser KS, Pleasants JM, Mattila HR, Siegfriedi BD, Dively GP (2001) Impact of Bt corn pollen on monarch butterfly populations: a risk assessment. PNAS 98:11937–11942

Shrader-Frechete K (2007) Nanotoxicology and ethical considerations for informed consent. Nanoethics 1:47–56

Singer P, Daar AS (2000) Avoiding frankendrugs. Nat Biotechnol 18:1225

Singer PA, Salamanca-Buentello F, Daar AS (2005) Harnessing nanotechnology to improve global equity. Issues in Science and Technology 21(4):57–64 Summer

Skokstad E (2005) Embattled Berkeley ecologist wins tenure. Science 308:1239

SourceWatch (2007) Government-industry revolving door. Retrieved August 8, 2007 from http://www.sourcewatch.org/index.php?title=Government-industry_revolving_door

Stitch S (1978) The recombinant DNA debate. Philos Public Aff 7:187–205

Taylor MR (2003) Rethinking U.S. leadership in food biotechnology. Nat Biotechnol 21:852–854

Taylor M, Tick JS (2003) Post-market oversight of biotech foods. Pew initiative on food and biotechnology. Retrieved August 8, 2007 from http://www.pewagbiotech.org

Taylor MR (2006) Regulating the products of nanotechnology: does FDA have the tools it needs? Project on emerging nanotechnologies. Washington, DC: PEN 5. Retrieved August 7, 2007 from http://www.nanotechproject.org

Thompson P (2007) Food biotechnology in ethical perspective, 2nd edn. Springer, Dordrecht, Netherlands

Toumey C (2006) Science and democracy. Nature Nanotechnol 1:6–7

Tyler TR, Boeckmann RJ, Smith HJ, Huo YJ (1997) Social justice in a diverse society. Westview, Boulder, CO

USDA (2007) Adoption of genetically engineered crops in the U.S. Retrieved August 8, 2007 from http://www.ers.usda.gov/Data/BiotechCrops/

Valent F, Little DA, Bertollini R, Nemer LE, Barbanc G, Tamburlini G (2004) Burden of disease attributable to selected environmental factors and injury among children and adolescents in Europe. Lancet 363:2032–2039

Wilsdon J, Willis R (2004) See-through science. Demos, London Retrieved August 8, 2007 from www.demos.co.uk